SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Kwan P & Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000;342:3149.
  • 2
    Mattson RH, Cramer JA, Collins JF. VA Epilepsy Cooperative Study No. 264 Group: a comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. N Engl J Med 1992;327:76571.
  • 3
    Richens A, Davidson DLW, Cartlidge NEF, et al. A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. J Neurol Neurosurg Psychiatry 1994;57:6827.
  • 4
    Brodie MJ, Richens A, Yuen AWC. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995;345:4769.
  • 5
    Beydoun A. Monotherapy trials of new antiepileptic drugs. Epilepsia 1997;38(suppl 9):S2131.
  • 6
    ILAE Commission on Antiepileptic Drugs. Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy. Epilepsia 1998;39:799803.
  • 7
    Chadwick D. Monotherapy clinical trials of new antiepileptic drugs: design, indications, and controversies. Epilepsia 1997;38(suppl 9):S1620.
  • 8
    Perucca E. Principles of drug treatment. In: ShorvonS, DreifussF, FishD, et al., eds. The treatment of epilepsy. Oxford: Blackwell Science, 1996:15268.
  • 9
    Walker MC & Sander JWAS. Difficulties in extrapolating from clinical trial data to clinical practice: the case of antiepileptic drugs. Neurology 1997;49:3337.
  • 10
    Mant D. Can randomised trials inform clinical decisions about individual patients? Lancet 1999;353:7436.
  • 11
    Pocock SJ & Elbourne DR. Randomized trials or observational tribulations? N Engl J Med 2000;342:19079.
  • 12
    Stephen LJ, Sills GJ, Brodie MJ. Topiramate in refractory epilepsy: a prospective observational study. Epilepsia 2000;41:97780.
  • 13
    Tobias E, Brodie AF, Brodie MJ. An outcome audit at the epilepsy clinic: results from 1000 consecutive referrals. Seizure 1994;3:3743.
  • 14
    Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:38999.
  • 15
    Commission on Epidemiology and Prognosis. Guidelines for epidemiological studies on epilepsy. Epilepsia 1993;34:5926.
  • 16
    Brodie MJ & Kwan P. The star systems: overview and use in determining antiepileptic drug choice. CNS Drugs 2001;18:112.
  • 17
    Brodie MJ & French JA. Management of epilepsy in adolescents and adults. Lancet 2000;356:3239.
  • 18
    Brodie MJ & Dichter MA. Antiepileptic drugs. N Engl J Med 1996;334:16875.
  • 19
    Dichter MA & Brodie MJ. New antiepileptic drugs. N Engl J Med 1996;334:158390.
  • 20
    McKee PJW, Larkin JG, Brodie AF, et al. Five years of anticonvulsant monitoring on site at the epilepsy clinic. Ther Drug Monit 1993;15:8390.
  • 21
    Heller AJ, Chesterman P, Elwes RDC, et al. Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial. J Neurol Neurosurg Psychiatry 1995;58:4450.
  • 22
    De Silva M, MacArdle B, McGowan M, et al. Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy. Lancet 1996;347:70913.
  • 23
    Brodie MJ, Overstall PW, Giorgi L, UK Lamotrigine Elderly Study Group, et al. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsy Res 1999;37:817.
  • 24
    Reynolds EH, Heller AJ, Chadwick D. Valproate versus carbamazepine for seizures [Letter]. N Engl J Med 1993;328:2078.
  • 25
    Semah F, Picot M-C, Adam C, et al. Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology 1998;51:125662.
  • 26
    Stephen LJ, Kwan P, Brodie MJ. Does the cause of localisation-related epilepsy influence the response to antiepileptic drug treatment? Epilepsia 2001;42:35762.
  • 27
    Roses AD. Pharmacogenetics and future drug development and delivery. Lancet 2000;355:135861.
  • 28
    Chadwick DW, Anhut H, Greiner M, et al. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. Neurology 1998;51:12828.
  • 29
    Privitera MD, Brodie MJ, Neto S, et al. Topiramate versus investigator choice of carbamazepine or valproate as monotherapy in newly diagnosed epilepsy. Epilepsia 2000;41(suppl 7):934.
  • 30
    Mattson RH, Cramer JA, Collins JF, et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalised tonic-clonic seizures. N Engl J Med 1985;313:14551.